Abstract
MP-20.17: Dose Reduction of Bacillus Calmette-Guérin (BCG) in the Treatment of Carcinoma In Situ(CIS) of the Bladder with a Less Intense and Shorter Maintenance Regimen: A 15 Year Experience
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have